Latest News

No Results Found

Try adjusting your search to find what you’re looking for.


Illumina Ventures Announces Strategic New Additions to its Investment Team

Illumina Ventures, a genomics and precision health focused venture firm, today announced additions to its investment team. Abhijit “Ron” Mazumder, PhD, MBA, joins as a Partner and Lisa Alderson, MBA as an Entrepreneur in Residence.

Read More

Illumina Ventures Announces Expansion Of Its Europe Team

Illumina Ventures announced the addition of four new members to its European team. Arnaud Autret, PhD, MSc, will be Principal and Head of European Operations, William Byrne, PhD, be an Associate – Europe, and Ronan Byrne and Ivan Coulter, PhD, BSc, will serve as Venture Advisors – Europe.

Read More

Illumina Ventures Announces Promotion and Additions to its Investment Team

Illumina Ventures, today announced the promotion of Malek Faham, MD, PhD, to Chief Scientist having previously served as both a Venture Partner and Entrepreneur in Residence (EIR). In addition, Charles Lin, PhD, has joined the team as a Principal, and Dave Johnson, PhD, has joined as an Entrepreneur in Residence.

Read More

NVCA Member Spotlight: Illumina Ventures

National Venture Capital Association interviews Nick Naclerio, Founding Partner at Illumina Ventures, to learn more about the firm... Illumina Ventures invests in early-stage life science companies with a particular focus on genomics and precision health. Our team and our unique relationship with Illumina, Inc. (NASDAQ: ILMN) is what sets us apart from other firms. Our members have been both ...

Read More